KIAA1429 promotes gastric cancer progression by destabilizing RASD1 mRNA in an m6A-YTHDF2-dependent manner
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
KIAA1429 promotes gastric cancer progression by destabilizing RASD1 mRNA in an m6A-YTHDF2-dependent manner ; volume:22 ; number:1 ; day:20 ; month:6 ; year:2024 ; pages:1-15 ; date:12.2024
Journal of translational medicine ; 22, Heft 1 (20.6.2024), 1-15, 12.2024
- Urheber
-
Ren, Mengting
Pan, Hanghai
Zhou, Xinxin
Yu, Mosang
Ji, Feng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-024-05375-5
- URN
-
urn:nbn:de:101:1-2409160922501.791464665251
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ren, Mengting
- Pan, Hanghai
- Zhou, Xinxin
- Yu, Mosang
- Ji, Feng
- SpringerLink (Online service)
Ähnliche Objekte (12)
SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner
Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer
FMR1 promotes the progression of colorectal cancer cell by stabilizing EGFR mRNA in an m6A-dependent manner
Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation
METTL14-mediated m6A mRNA modification of G6PD promotes lung adenocarcinoma
hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner
HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m6A-YTHDF2-dependent manner
METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner
YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner
Correction: HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
m6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer
SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner
Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer
FMR1 promotes the progression of colorectal cancer cell by stabilizing EGFR mRNA in an m6A-dependent manner
Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation
METTL14-mediated m6A mRNA modification of G6PD promotes lung adenocarcinoma
hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner
HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m6A-YTHDF2-dependent manner
METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner
YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner
Correction: HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
m6A RNA methylation-mediated NDUFA4 promotes cell proliferation and metabolism in gastric cancer
SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner
Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer
FMR1 promotes the progression of colorectal cancer cell by stabilizing EGFR mRNA in an m6A-dependent manner
Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation
METTL14-mediated m6A mRNA modification of G6PD promotes lung adenocarcinoma
hnRNPA2B1 promotes the occurrence and progression of hepatocellular carcinoma by downregulating PCK1 mRNA via a m6A RNA methylation manner
HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma
METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m6A-YTHDF2-dependent manner
METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m6A-dependent manner
YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner
Correction: HNRNPA2B1-mediated m6A modification of TLR4 mRNA promotes progression of multiple myeloma